NAD+ supplementation augments the efficacy of the PARP1 inhibitor PJ34 in a 6-OHDA-induced model of Parkinson’s disease

作者：Mengling Hu, Xiaoqian Li, Dongsheng Fan, Lu Yu, Ren Fan, Jianming Wu, Jianing Mi, Yang Zheng, Xiaogang Zhou, Dalian Qin, Anguo Wu · 发表于：Genes & Diseases · 年份：2025 · DOI：10.1016/j.gendis.2025.101783 · 被引用次数：2 · 研究领域：Calcium signaling and nucleotide metabolism、PARP inhibition in cancer therapy、Sirtuins and Resveratrol in Medicine